Cancer Health Treatment Update Wave of New Therapies Improve Outcomes for Patients with Multiple Myeloma New drugs to treat multiple myeloma are producing better results with fewer side effects. For Early-Stage Breast Cancer, Weekly Radiation Is as Safe as Daily Higher, less frequent doses are more convenient—and keep people out of the hospital—with a similar rate of side effects. FDA Approves Tecentriq Combo for Advanced Melanoma Tecentriq plus two targeted medications extended progression-free survival by 4.5 months. How CRISPR Is Changing Cancer Research and Treatment The gene-editing tool can alter the DNA of human cells like a precise pair of scissors.  Population-Wide BRCA Testing Could Prevent Many Deaths From Breast and Ovarian Cancers Screening would be especially cost effective in high-income nations. Click here for Cancer Health's coverage of the novel coronavirus and COVID-19, including how they affect people living with cancer. News From the AACR Annual Meeting & COVID-19 and Cancer Meeting See all our reports from these recent virtual cancer research conferences. Cancer Health Summer 2020 Check out our new print edition! Advertisement Newsfeed For Early-Stage Breast Cancer, Weekly Radiation Is as Safe as Daily Free Webinar for Cancer Caregivers on COVID-19 and Cancer Care Many Older Americans Get Unneeded Cancer Screenings Michelle Obama Reveals COVID-19 Also Affects Her Mental Health Blog: Food and Drug Administration (FDA) FDA Approves Blenrep for Multiple Myeloma FDA Approves Monjuvi for Diffuse Large B-cell Lymphoma FDA Approves Tecentriq Combo for Advanced Melanoma FDA Approves New Therapy for Myelodysplastic Syndromes That Can Be Taken at Home Newsfeed For Early-Stage Breast Cancer, Weekly Radiation Is as Safe as Daily Free Webinar for Cancer Caregivers on COVID-19 and Cancer Care Many Older Americans Get Unneeded Cancer Screenings Michelle Obama Reveals COVID-19 Also Affects Her Mental Health Blog: Food and Drug Administration (FDA) FDA Approves Blenrep for Multiple Myeloma FDA Approves Monjuvi for Diffuse Large B-cell Lymphoma FDA Approves Tecentriq Combo for Advanced Melanoma FDA Approves New Therapy for Myelodysplastic Syndromes That Can Be Taken at Home

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: